close
MENU
General Business
3 mins to read

Speculation mounts over Infratil Aussie healthcare play

M-Co and Infratil keeping mum on bid for Aussie cancer care provider.

Plans by listed infrastructure investor Infratil and its manager Morrison & Co to bolster their healthcare portfolio may have passed another milestone today when first-round bids for the sale of Australia’s Icon Group became due.

While Infratil and M-Co remain tight lipped on the subject,

Want to read more? It's easy.

Choose your best value subscription option

Student

Exclusive FREE offer for uni students studying at a New Zealand university (valued at $499).
Individual
Group membership
NBR Marketplace

Yearly Premium Online Subscription

NZ$499.00 / yearly

Smartphone Only Annual Subscription

NZ$249.00 / yearly

Monthly Premium Online Subscription

NZ$49.95 / monthly

Smartphone Only Subscription

NZ$29.95 / monthly

Premium Group Membership 10 Users

NZ$385+GST / monthly

$38.5 per user - Pay by monthly credit card debit

Premium Group Membership 20 Users

NZ$660+GST / monthly

$33 per user - Pay by monthly credit card debit

Premium Group Membership 50 Users

NZ$1375+GST / monthly

$27.5 per user - Pay by monthly credit card debit

Premium Group Membership 100 Users

NZ$2100+GST / monthly

$21 per user - Pay by monthly credit card debit

Yearly Premium Online Subscription + NBR Marketplace

NZ$499.00 / yearly

Already have an account? Login
Daniel Riordan Wed, 08 Sep 2021
Contact the Writer: daniel@nbr.co.nz
News tip? Question? Typo? Let us know: editor@nbr.co.nz
© All content copyright NBR. Do not reproduce in any form without permission, even if you have a paid subscription.
Speculation mounts over Infratil Aussie healthcare play
General Business,
88859
true